Reata Pharmaceuticals Price History
RETADelisted Stock | USD 109.67 3.31 2.93% |
If you're considering investing in Reata Stock, it is important to understand the factors that can impact its price. As of today, the current price of Reata Pharmaceuticals stands at 109.67, as last reported on the 2nd of December, with the highest price reaching 115.23 and the lowest price hitting 109.66 during the day. We have found twenty-nine technical indicators for Reata Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Reata Pharmaceuticals' Coefficient Of Variation of 1897.93, semi deviation of 3.31, and Risk Adjusted Performance of 0.0483 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Reata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Reata |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
RETA |
Based on monthly moving average Reata Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reata Pharmaceuticals by adding Reata Pharmaceuticals to a well-diversified portfolio.
Reata Pharmaceuticals Stock Price History Chart
There are several ways to analyze Reata Stock price data. The simplest method is using a basic Reata candlestick price chart, which shows Reata Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Reata Stock Price History Data
The price series of Reata Pharmaceuticals for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 33.79 with a coefficient of variation of 8.77. The price distribution for the period has arithmetic mean of 97.61. The median price for the last 90 days is 98.86.Open | High | Low | Close | Volume | ||
12/02/2024 | 112.98 | 115.23 | 109.66 | 109.67 | ||
07/24/2023 | 112.98 | 115.23 | 109.66 | 109.67 | 351,058 | |
07/21/2023 | 110.59 | 112.23 | 108.84 | 110.86 | 219,671 | |
07/20/2023 | 112.91 | 113.09 | 109.97 | 110.11 | 531,037 | |
07/19/2023 | 110.26 | 113.61 | 108.04 | 113.01 | 602,706 | |
07/18/2023 | 111.20 | 111.20 | 108.04 | 109.15 | 381,582 | |
07/17/2023 | 109.40 | 111.24 | 108.88 | 110.47 | 301,667 | |
07/14/2023 | 107.69 | 110.37 | 107.69 | 109.13 | 346,884 | |
07/13/2023 | 109.25 | 110.72 | 107.18 | 107.71 | 341,874 | |
07/12/2023 | 110.00 | 110.86 | 107.76 | 109.04 | 451,900 | |
07/11/2023 | 107.45 | 109.99 | 104.82 | 109.32 | 570,762 | |
07/10/2023 | 104.36 | 108.61 | 103.60 | 107.25 | 368,087 | |
07/07/2023 | 108.00 | 108.50 | 103.78 | 104.37 | 627,871 | |
07/06/2023 | 104.80 | 108.00 | 103.18 | 107.89 | 683,653 | |
07/05/2023 | 102.88 | 104.58 | 102.27 | 103.90 | 347,677 | |
07/03/2023 | 102.00 | 103.59 | 101.64 | 102.88 | 233,431 | |
06/30/2023 | 101.23 | 104.59 | 99.91 | 101.96 | 693,647 | |
06/29/2023 | 100.48 | 104.79 | 99.45 | 100.90 | 912,118 | |
06/28/2023 | 98.03 | 103.26 | 94.31 | 98.83 | 2,096,237 | |
06/27/2023 | 91.54 | 92.89 | 88.80 | 92.39 | 521,617 | |
06/26/2023 | 93.16 | 94.52 | 88.90 | 90.01 | 434,068 | |
06/23/2023 | 96.18 | 96.41 | 92.91 | 93.79 | 804,054 | |
06/22/2023 | 95.92 | 99.53 | 94.51 | 97.11 | 497,153 | |
06/21/2023 | 93.68 | 96.39 | 92.22 | 95.76 | 447,527 | |
06/20/2023 | 92.04 | 94.10 | 90.70 | 93.15 | 345,514 | |
06/16/2023 | 96.89 | 97.67 | 91.36 | 93.38 | 1,454,279 | |
06/15/2023 | 100.96 | 100.99 | 87.66 | 93.61 | 2,254,033 | |
06/14/2023 | 104.31 | 105.45 | 100.21 | 102.22 | 445,800 | |
06/13/2023 | 98.30 | 105.55 | 98.30 | 104.31 | 936,200 | |
06/12/2023 | 96.00 | 99.98 | 95.46 | 99.12 | 970,002 | |
06/09/2023 | 93.96 | 94.86 | 93.06 | 93.80 | 619,164 | |
06/08/2023 | 94.09 | 95.07 | 93.21 | 94.10 | 289,816 | |
06/07/2023 | 94.11 | 95.44 | 92.58 | 93.61 | 343,062 | |
06/06/2023 | 91.96 | 94.75 | 91.77 | 93.93 | 399,742 | |
06/05/2023 | 91.90 | 94.50 | 90.46 | 92.08 | 356,613 | |
06/02/2023 | 91.14 | 93.66 | 89.62 | 93.02 | 491,041 | |
06/01/2023 | 90.66 | 92.49 | 88.59 | 91.13 | 502,600 | |
05/31/2023 | 89.72 | 90.98 | 87.82 | 90.05 | 697,424 | |
05/30/2023 | 92.00 | 92.51 | 88.78 | 89.70 | 797,728 | |
05/26/2023 | 92.54 | 94.20 | 91.09 | 92.31 | 378,106 | |
05/25/2023 | 95.19 | 95.73 | 90.59 | 92.54 | 1,070,973 | |
05/24/2023 | 88.00 | 96.12 | 85.30 | 95.36 | 3,472,925 | |
05/23/2023 | 79.63 | 80.91 | 78.40 | 79.22 | 678,278 | |
05/22/2023 | 79.99 | 81.51 | 77.74 | 79.42 | 939,345 | |
05/19/2023 | 82.29 | 83.33 | 79.84 | 79.98 | 1,133,956 | |
05/18/2023 | 81.40 | 81.99 | 79.17 | 81.19 | 952,410 | |
05/17/2023 | 85.00 | 85.32 | 81.96 | 82.04 | 501,066 | |
05/16/2023 | 83.67 | 86.80 | 80.30 | 85.02 | 798,288 | |
05/15/2023 | 86.06 | 86.56 | 83.60 | 84.60 | 634,590 | |
05/12/2023 | 87.87 | 88.18 | 83.44 | 85.63 | 767,000 | |
05/11/2023 | 88.41 | 89.96 | 85.02 | 88.01 | 1,070,205 | |
05/10/2023 | 89.50 | 92.20 | 76.56 | 90.38 | 5,040,928 | |
05/09/2023 | 103.84 | 106.61 | 103.53 | 105.37 | 570,252 | |
05/08/2023 | 104.37 | 105.98 | 100.91 | 104.78 | 574,734 | |
05/05/2023 | 103.30 | 105.29 | 102.87 | 104.79 | 570,951 | |
05/04/2023 | 101.42 | 102.63 | 99.76 | 102.40 | 480,487 | |
05/03/2023 | 100.72 | 104.36 | 99.99 | 102.04 | 621,073 | |
05/02/2023 | 99.58 | 100.93 | 98.02 | 99.84 | 328,269 | |
05/01/2023 | 98.00 | 101.36 | 98.00 | 99.79 | 291,219 | |
04/28/2023 | 97.89 | 99.62 | 96.51 | 98.86 | 309,439 | |
04/27/2023 | 98.82 | 98.92 | 96.21 | 98.23 | 417,900 |
About Reata Pharmaceuticals Stock history
Reata Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reata Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reata Pharmaceuticals stock prices may prove useful in developing a viable investing in Reata Pharmaceuticals
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas. Reata Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 346 people.
Reata Pharmaceuticals Stock Technical Analysis
Reata Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
Reata Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Reata Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0483 | |||
Jensen Alpha | 0.2665 | |||
Total Risk Alpha | (0.46) | |||
Sortino Ratio | 0.0191 | |||
Treynor Ratio | (0.35) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |